tiprankstipranks
pc:popai

Popai Health

Digital Health
Popai Health is the Patient Conversation Intelligence company that transforms patient conversations into actions through Voice AI. The company helps health systems, medical groups, health plans, and ACOs eliminate their biggest blind spot in population health management by capturing and analyzing the 65% of patient engagement that happens over the phone but remains untapped.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$22M
Total Amount Raised$22M
Total Funding Rounds2
Total Funding Rounds2
Latest Funding Amount$11M
Latest Funding Amount$11M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation―
Post-Money Valuation―

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Nov 03, 2025
Seed Round
$11.00M
―
Nov 03, 2025
Investment
$11.00M
―

Investors

Investor Name
Funding Round
NEA
Seed Round
Team8
Seed Round
NEA
Investment
Team8
Investment

Related News and Analysis

Talkiatry Partners With AMGA to Scale In-Network Psychiatric Access Nationwide

Talkiatry Partners With AMGA to Scale In-Network Psychiatric Access Nationwide

New updates have been reported about Talkiatry. Talkiatry has entered a strategic partnership with AMGA to expand in-network...
23h ago
TALKI
Fibr AI Unveils Ads and LLM Personalization Tools to Lift Conversion and Cut Acquisition Costs

Fibr AI Unveils Ads and LLM Personalization Tools to Lift Conversion and Cut Acquisition Costs

New updates have been reported about Fibr AI. Fibr AI has introduced two web personalization capabilities aimed at...
23h ago
FIBRA
TransPerfect Expands Media Footprint With Acquisition of Italy’s Studio Emme

TransPerfect Expands Media Footprint With Acquisition of Italy’s Studio Emme

New updates have been reported about TransPerfect. TransPerfect has acquired Rome-based Studio Emme SpA, a long-established dubbing and...
23h ago
TRA2H
Lettuce Financial to Acquire Carry, Adding $225 Million Retirement Platform for Solopreneurs

Lettuce Financial to Acquire Carry, Adding $225 Million Retirement Platform for Solopreneurs

New updates have been reported about Lettuce Financial. Lettuce Financial plans to acquire Carry’s retirement and investing platform,...
23h ago
LETTU
BQP Backs Quantum Hubs Legislation to Deepen Role in New York’s Growing Quantum Ecosystem

BQP Backs Quantum Hubs Legislation to Deepen Role in New York’s Growing Quantum Ecosystem

New updates have been reported about BQP. BQP is positioning itself at the center of New York’s quantum...
23h ago
BQPXX
Cala Health Secures FDA Clearance for Next-Gen Wearable Tremor Device Cala kIQ Plus

Cala Health Secures FDA Clearance for Next-Gen Wearable Tremor Device Cala kIQ Plus

New updates have been reported about Cala Health. Cala Health has received U.S. Food and Drug Administration clearance...
23h ago
CALAH
Verismo to Unveil First-in-Human KIR-CAR Data for SynKIR-110 and SynKIR-310 at AACR 2026

Verismo to Unveil First-in-Human KIR-CAR Data for SynKIR-110 and SynKIR-310 at AACR 2026

New updates have been reported about Verismo Therapeutics. Verismo Therapeutics will showcase pivotal first-in-human and preclinical data for...
24h ago
VER0L
Verismo Therapeutics Secures $28 Million to Advance KIR-CAR Trials Ahead of Key 2026 Data Readout

Verismo Therapeutics Secures $28 Million to Advance KIR-CAR Trials Ahead of Key 2026 Data Readout

New updates have been reported about Verismo Therapeutics. Verismo Therapeutics has obtained a $28 million capital infusion from...
24h ago
VER0L
Sonire Therapeutics Raises $18 Million to Drive Breakthrough HIFU Pancreatic Cancer Program and U.S. Expansion

Sonire Therapeutics Raises $18 Million to Drive Breakthrough HIFU Pancreatic Cancer Program and U.S. Expansion

New updates have been reported about Sonire Therapeutics. Sonire Therapeutics has secured $18 million in Series A funding...
24h ago
SONIR
Gallant Advances Feline OA Stem Cell Program With Positive Data and FDA Fast-Track Pathway

Gallant Advances Feline OA Stem Cell Program With Positive Data and FDA Fast-Track Pathway

New updates have been reported about Gallant. Gallant has reported positive pilot data for its intravenous uterine-derived mesenchymal...
24h ago
GAL3M